Optical coherence tomography uses reflected near-infrared light to produce cross-sectional images of the retina. The resulting image shows the central foveal region in profile, allowing the measurement to be based on visible retinal structure rather than on a clinical estimate alone. This provides a reproducible structural value for ophthalmic assessment and follow-up.
OCT software identifies anatomical boundaries within the retinal image and calculates the distance between them. The measurement therefore depends on locating the relevant tissue interfaces consistently across the central foveal region. Automated boundary analysis supports efficient evaluation and helps create standardized values that clinicians and researchers can compare across examinations.
Serial changes can reflect different structural processes in the retina. An increase may reveal fluid accumulation associated with retinal edema, whereas a decrease may indicate tissue loss. Interpreting the direction of change alongside the patient’s condition helps clinicians assess disease behavior, follow progression, and judge whether retinal structure is responding to treatment.
Because the value summarizes structural change at the foveal center, it can be tracked across multiple OCT examinations. Repeated measurements help distinguish a stable finding from an evolving abnormality, while standardized values support comparisons between time points. This makes the measurement useful for monitoring disease, evaluating prognosis, and documenting treatment-related changes.
An OCT system first uses reflected near-infrared light to create a cross-sectional retinal image. Software then identifies the relevant anatomical boundaries and calculates the separation between them at the central foveal region. The resulting measurement can be recorded and compared with later examinations, providing a structured approach to assessing retinal changes.
Clinicians use the measurement when assessing retinal edema and when monitoring conditions such as diabetic macular edema and age-related macular degeneration. In these settings, thickness changes can provide structural evidence of fluid accumulation or tissue loss. The measurement therefore contributes to ongoing evaluation rather than serving only as a one-time observational finding.
Changes in central macular thickness over time can show whether retinal structure is changing after treatment. A measured change may correspond to reduced or increased fluid accumulation, or to tissue loss, depending on the clinical context. Tracking these findings gives clinicians structural information for evaluating response and supporting continued monitoring.
The measurement provides a standardized structural outcome that can be followed across examinations and compared between research observations. Because OCT software calculates the distance between identified retinal boundaries, studies can use a consistent metric when examining disease-related changes, prognosis, or treatment response. This supports structured comparisons in investigations of retinal disorders.